ANALYSIS OF THE LIST OF DRUGS IN TUE TINH HOSPITAL – VIETNAM UNIVERSITY OF TRADITIONAL MEDICINE IN 2021
Main Article Content
Abstract
Research objectives: Describe the structure of the list of used drugs under the ABC/VEN analysis at Tue Tinh Hospital in 2021. Research subjects: List of drugs used at Tue Tinh Hospital in 2021 (including
282 items of pharmaceutical drugs, 13 items of traditional medicine or from herbal medicine, as well as 170 items of herbal ingredients conVerted into 338 items of herbal remedies). Research Methods: A cross-sectional descriptiVe study. Result: 633 drug items, equiValent to 6,893.4 million VND. Single- ingredient drugs accounted for the majority with 238 items (84.4%), equiValent to 2,411.1 million VND (66.8%). Brand-name drugs accounted for a low percentage of 28/282 items (13.1%) and 24.6% of use-Value. Although most of the drugs used are of domestic origin, their use-Value is low. The ratios are 18.4%, 33.2%, and 22% for medicinal drugs; drugs of traditional medicines or from herbal ingredients; and herbal remedies respectiVely. Medicinal drugs are mainly used orally; while drugs of traditional medicines or from herbal ingredients and herbal remedies are used 100% orally. The structure of drugs used according to ABC classification in terms of use Value is consistent with the regulations [1]: 79.8% for A ranking, 15.1% for B ranking and 5.1% for C ranking. AN drug group has only 1 item, accounting for 1.1% of the use Value. A number of drugs with the same actiVe ingredient, content and dosage form are used in both A, B and C rankings. Conclusion: The structure of the list of drugs used at Tue Tinh Hospital is quite reasonable, howeVer, it is necessary to increase the Value of using domestically produced drugs; while limiting unnecessary drugs of AN and BN groups to saVe the budget and reduce the financial burden on the hospital.
Article Details
References
2. Bộ Y tế (2018), Niên giám thống kê y tế năm
2018, Hà Nội.
3. Chính phủ (2014), Quyết định số 68/QĐ-TTg Phê duyệt Chiến lược quốc gia phát triển ngành Dược Việt Nam giai đoạn đến năm 2020 và tầm nhìn đến năm 2030, Hà Nội.
4. A. Angelino, D. T. Khanh, N. A. Ha et al. (2017), Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market, International
Journal of EnVironmental Research and Public Health, Vol. 14, No. 9, pp. 976.
5. Management Sciences for Health (2012), MDS- 3: Managing Access to Medicines and Health Technologies, Management Sciences for Health, USA
6. World Health Organization (2004), Drug and therapeutic commitee: A practical guide, France, pp.1.